Staphylococcal osteomyelitis in children. Success with cephaloridine-cephalexin therapy.
D000284:Administration, Oral; D000293:Adolescent; D001741:Black or African American; D002506:Cephalexin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D002509:Cephaloridine / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007223:Infant; D007273:Injections, Intramuscular; D008297:Male; D010019:Osteomyelitis / Q000628:therapy*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013997:Time Factors
D002509:Cephaloridine; D002506:Cephalexin